Publication

Last updated: 2023-03-09

Mariko Esumi's selected papers

  1. Ohni S, Yamaguchi H, Hirotani Y, Nakanishi y, Midorikawa Y, Sugitani M, Naruse H, Nakayama T, Makishima M, Esumi M. Direct molecular evidence for both multicentric and monoclonal carcinogenesis followed by transdifferentiation from hepatocellular carcinoma to cholangiocarcinoma in a case of metachronous liver cancer. Oncol Lett 23: 22, 2022
  2. Kobayashi H, Nakai T, Nakanishi Y, Esumi M, Masuda S. Phylogenetic analysis of combined lobular and ductal carcinoma of the breast. Mol Med Rep 24: 718, 2021
  3. Nakahashi M, Esumi M, Tokuhashi Y. Detection of apoptosis and matrical degeneration within the intervertebral discs of rats due to passive cigarette smoking. PLoS One 14: e0218298, 2019
  4. Nakai T, Sakurada A, Endo T, Kobayashi H, Masuda S, Makishima M, Esumi M. Caution for simple sequence repeat number variation in the mitochondrial DNA D-loop to determine cancer-specific variants. Oncol Lett 17: 1883-1888, 2019
  5. Ishibashi M, Yamaguchi H, Hirotani Y, Sakurada A, Endo T, Sugitani M, Takayama T, Esumi M. Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers. Arch Virol 163: 855-865, 2018
  6. 糸井充穂,井上亮太郎,山口裕美,江角眞理子,大荷澄江,杉谷雅彦.がんゲノミクスによる腫瘍抗原とT細胞受容体解析から腫瘍免疫をイメージングする.日本大学医学部総合医学研究所紀要 6: 15-17, 2018
  7. Kudo I, Esumi M, Kusumi Y, Furusaka T, Oshima T. Particular gene upregulation and p53 heterogeneous expression in TP53-mutated maxillary carcinoma. Oncol Lett 14: 4633-4640, 2017
  8. Hasegawa H, Kusumi Y, Asakawa T, Maeda M, Oinuma T, Furusaka T, Oshima T, Esumi M. Expression of von Hippel–Lindau tumor suppressor protein (pVHL) characteristic of tongue cancer and proliferative lesions in tongue epithelium. BMC Cancer 17: 381, 2017
  9. Einaga N, Yoshida A, Noda H, Suemitsu M, Nakayama Y, Sakurada A, Kawaji Y, Yamaguchi H, Sasaki Y, Tokino T, Esumi M. Assessment of the quality of DNA from various formalin-fixed paraffin-embedded (FFPE) tissues and the use of this DNA for next-generation sequencing (NGS) with no artifactual mutation. PLOS ONE 12: e0176280, 2017
  10. Yamaguchi H, Kuroda K, Sugitani M, Takayama T, Hasegawa K, Esumi M. Transglutaminase 2 is upregulated in primary hepatocellular carcinoma with early recurrence as determined by proteomic profiles. Int J Oncol 50: 1749-1759, 2017
  11. Nakayama Y, Yamaguchi H, Einaga N, Esumi M. Pitfalls of DNA quantification using DNA-binding fluorescent dyes and suggested solutions. PLOS ONE 11: e0150528, 2016
  12. Numaguchi S, Esumi M, Sakamoto M, Endo M, Ebihara T, Soma H, Yoshida A, Tokuhashi Y. Passive cigarette smoking changes the circadian rhythm of clock genes in rat intervertebral discs. J Orthop Res 34: 39-47, 2016
  13. 江角眞理子、山口裕美、栄永直樹、中山裕貴、高山忠利、杉谷雅彦、野田博子、増田しのぶ、末光正昌、久山佳代、吉田明生、徳橋泰明:「ミクロゲノミクス」から、がんheterogeneityの分子基盤を解明する. 日本大学医学部総合医学研究所紀要 3: 1-6, 2015
  14. Esumi M, Ishibashi M, Yamaguchi H, Nakajima S, Tai Y, Kikuta S, Sugitani M, Takayama T, Tahara M, Takeda M, Wakita T. Transmembrane serine protease TMPRSS2 activates hepatitis C virus infection. Hepatology 61: 437-446, 2015
  15. Ishibashi M, Morita N, Nomura-Kawaguchi C, Shimizu Y, Wakita T, Esumi M. CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection. Arch Virol 159: 2949-2955, 2014
  16. 江角眞理子、海老原貴之、山口裕美、楠美嘉晃、黒田和道、尾花ゆかり、徳橋泰明:レーザーマイクロダイセクション・プロテオーム解析を用いた、椎間板変性の分子病態解析.日本大学医学部総合医学研究所紀要 1: 55-56, 2013
  17. Abe M, Tahara M, Sakai K, Yamaguchi H, Kanou K, Shirato K, Kawase M, Noda M, Kimura H, Matsuyama S, Fukuhara H, Mizuta K, Maenaka K, Ami Y, Esumi M, Kato A, Takeda M. TMPRSS2 is an activating protease for respiratory parainfluenza viruses. J Virol 87: 11930-11935, 2013
  18. Yamaguchi H, Matsumoto S, Ishibashi M, Hasegawa K, Sugitani M, Takayama T, Esumi M. β-Glucuronidase is a suitable internal control gene for mRNA quantitation in pathophysiological and non-pathological livers. Exp Mol Pathol 95: 131-135, 2013
  19. Yamaguchi H, Hasegawa K, Esumi M. Protein from the fraction remaining after RNA extraction is useful for proteomics but care must be exercised in its application. Exp Mol Pathol 95: 46-50, 2013
  20. Asakawa T, Esumi M, Endo S, Kida A, Ikeda M. A mutation at IVS1+5 of the von Hippel-Lindau gene resulting in intron retention in transcripts is not pathogenic in a patient with a tongue cancer? BMC Med Genet 13:23, 2012
  21. Taniguchi S, Ryu J, Seki M, Sumino T, Tokuhashi Y, Esumi M. Long-term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up-regulation of MMP-3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs. J Orthop Res 30: 673-678, 2012
  22. Takagi K, Takayama T, Nagase H, Moriguchi M, Wang X, Hirayamagi K, Suzuki T, Hasegawa H, Ochiai T, Yamaguchi N, Kochi M, Kimura M, Esumi M. High TSC22D3 and low GBP1 expression in the liver is a risk factor for early recurrence of hepatocellular carcinoma. Exp Ther Med 2: 425-431, 2011
  23. Kudo I, Esumi M, Kida A, Ikeda M. p53 mutation, but not in vitro predictor genes of therapeutic efficacy of cisplatin, is clinically relevant in comparing partial and complete responder cases of maxillary squamous cell carcinoma. Oncol Rep 24: 851-856, 2010
  24. Obikane H, Abiko Y, Ueno H, Kusumi Y, Esumi M, Mitsumata M. Effect of endothelial cell proliferation on atherogenesis: a role of p21(Sdi/Cip/Waf1) in monocyte adhesion to endothelial cells. Atherosclerosis 212(1): 116-122, 2010
  25. Shinojima Y, Terui T, Hara H, Kimura MT, Igarashi J, Wang X, Kawashima H, Kobayashi Y, Muroi S, Hayakawa S, Esumi M, Fujiwara K, Ghosh S, Yamamoto T, Held W, Nagase H. Identification and analysis of an early diagnostic marker for malignant melanoma: ZAR1 intra-genic differential methylation. J Dermatol Sci 59: 98-106, 2010
  26. Sueyoshi S, Mitsumata M, Kusumi Y, Niihashi M, Esumi M,Yamada T, Sakurai I. Increased expression of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma in human atherosclerosis. Pathol Res Pract 206: 429-438, 2010
  27. Ishibashi M, Wakita T, Esumi M. 2’-5’-oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro. Biochem Biophys Res Commun 392: 397-402, 2010

このウインドウを閉じる